Inositol and choline help emulsify and metabolize fats in the liver, aiding in their breakdown
Phase 3 trial data shows that ~28.7% average weight reduction is achieved by 68 weeks, with the largest improvements in metabolic markers fasting glucose, A1c, liver fat, blood pressure typically appearing by month 9
Its reduced IGFBP binding means that a greater proportion of the peptide remains free to interact with the IGF-1 receptor (IGF-1R), making it a more potent and predictable tool for in vitro research
Specifically as the topic of this article, what are the potential uses and benefits of liposomal glutathione
Autoimmune Thyroid Disease in Rheumatoid Arthritis: A Global Perspective
Gaby, MD in Townsend Letter for Doctors and Patients - December 2005